8-K//Current report
BridgeBio Pharma, Inc. 8-K
Accession 0001140361-25-039705
$BBIOCIK 0001743881operating
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:09 PM ET
Size
189.0 KB
Accession
0001140361-25-039705
Documents
- 8-Kef20057894_8k.htmPrimary
8-K
- EX-99.1ef20057894_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHbbio-20251029.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABbbio-20251029_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREbbio-20251029_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-25-039705-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLef20057894_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001743881
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:09 PM ET
- Size
- 189.0 KB